Concepedia

SLIT3 promotes myogenic differentiation as a novel therapeutic factor against muscle loss

Han Jin Cho, Hyeonmok Kim, Young‐Sun Lee, Sung Ah Moon, Jin‐Man Kim, Hanjun Kim, Min Ji Kim, Jiyoung Yu, Kyunggon Kim, In‐Jeoung Baek,

Journal of Cachexia Sarcopenia and Muscle · 2021 · 27 citations · 31 references

DOIFull text

Open access

Abstract

SLIT3 plays a sarcoprotective role by activating β-catenin signalling. SLIT3 LRRD2 can potentially be used as a therapeutic agent against muscle loss.

References

31

Sarcopenia: revised European consensus on definition and diagnosis

Alfonso J. Cruz‐Jentoft, Gülistan Bahat, Jürgen M. Bauer et al. · Age and Ageing · 2018 · 13.1K citations · Full text

RETRACTED: Hierarchical Organization of Guidance Receptors: Silencing of Netrin Attraction by Slit Through a Robo/DCC Receptor Complex

Elke Stein, Marc Tessier‐Lavigne · Science · 2001 · 598 citations

, , +25

Wnt Signaling Induces the Myogenic Specification of Resident CD45+ Adult Stem Cells during Muscle Regeneration

Anna Polesskaya, Patrick Seale, Michael A. Rudnicki · Cell · 2003 · 515 citations · Full text

, , +10

SLIT2-Mediated ROBO2 Signaling Restricts Kidney Induction to a Single Site

Uta Grieshammer, Le Ma, Andrew Plump et al. · Developmental Cell · 2004 · 384 citations · Full text

, , +12

Targeting skeletal endothelium to ameliorate bone loss

Ren Xu, Alisha R. Yallowitz, An Qin et al. · Nature Medicine · 2018 · 349 citations · Full text

, , +9